41P Efficacy of First-Line (1L) Nivolumab (N) + Ipilimumab (I) by Tumor Histologic Subtype in Patients (pts) with Metastatic Nonsquamous NSCLC (Mnsq-Nsclc)
Journal of Thoracic Oncology(2023)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Journal of Thoracic Oncology(2023)